These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19489873)

  • 1. Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.
    Sathyapalan T; Cho L; Kilpatrick ES; Le Roux CW; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):423-5. PubMed ID: 19489873
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.
    Sathyapalan T; Dakroury Y; Ahmed L; Elshewehy AM; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):671-3. PubMed ID: 27256522
    [No Abstract]   [Full Text] [Related]  

  • 3. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liraglutide in polycystic ovary syndrome].
    Gómez-Pérez AM; Fernández-García JC; Mancha Doblas I; Tinahones FJ
    Med Clin (Barc); 2014 Sep; 143(6):283-4. PubMed ID: 24456922
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome.
    Oppelt PG; Mueller A; Jentsch K; Kronawitter D; Reissmann C; Dittrich R; Beckmann MW; Cupisti S
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):633-7. PubMed ID: 19998243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice.
    Al-Barazanji K; McNulty J; Binz J; Generaux C; Benson W; Young A; Chen L
    J Pharmacol Exp Ther; 2015 Jun; 353(3):496-504. PubMed ID: 25770135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin on IGF-1 and IGFBP-1 levels in obese patients with polycystic ovary syndrome.
    Seibel SA; Chou KH; Capp E; Spritzer PM; von Eye Corleta H
    Eur J Obstet Gynecol Reprod Biol; 2008 May; 138(1):122-4. PubMed ID: 17350746
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ; Evans WS; Pasquali R
    N Engl J Med; 1998 Jun; 338(26):1876-80. PubMed ID: 9637806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in polycystic ovary syndrome.
    Mascitelli L; Pezzetta F; Goldstein MR
    N Engl J Med; 2008 Apr; 358(17):1867-8; author reply 1868. PubMed ID: 18437729
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH; von Eye Corleta H; Capp E; Spritzer PM
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aerobic exercise with or without metformin on plasma incretins in type 2 diabetes.
    Eshghi SR; Bell GJ; Boulé NG
    Can J Diabetes; 2013 Dec; 37(6):375-80. PubMed ID: 24321717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study.
    Pontikis C; Yavropoulou MP; Toulis KA; Kotsa K; Kazakos K; Papazisi A; Gotzamani-Psarakou A; Yovos JG
    J Womens Health (Larchmt); 2011 Jun; 20(6):971-6. PubMed ID: 21671782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.
    Morin-Papunen LC; Koivunen RM; Tomás C; Ruokonen A; Martikainen HK
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2566-8. PubMed ID: 9661644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.
    Sathyapalan T; Cho LW; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):931-5. PubMed ID: 18410553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug?
    Legro RS
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4218-20. PubMed ID: 18987279
    [No Abstract]   [Full Text] [Related]  

  • 18. New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser.
    Cho YM; Kieffer TJ
    Diabetologia; 2011 Feb; 54(2):219-22. PubMed ID: 21116606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile.
    Aghahosseini M; Aleyaseen A; Safdarian L; Moddaress-Hashemi S; Mofid B; Kashani L
    Arch Gynecol Obstet; 2010 Dec; 282(6):691-4. PubMed ID: 20596715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.